Skip to Content

Pharmaceutical Sales 2005

The following is a list of the top 200 pharmaceutical drugs by retail sales in 2005, listed by U.S. sales value and brand name.
Quarterly top 100 prescription sales data now available, from Q1 2011.

Top 200 Drugs for 2005 by Sales

(By Units)

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Rank Drug Current Manufacturer Total Sales ($000) % Change 2004
1 Lipitor Pfizer Inc. 6,320,522 6.0%
2 (2) Nexium AstraZeneca 3,436,794 16.0%
3 (1) Prevacid Takeda Pharmaceuticals U.S.A., Inc. 3,327,919 4.1%
4 (1) Zocor Merck 3,106,628 -1.4%
5 (1) Advair Diskus GlaxoSmithKline 2,830,047 21.8%
6 (1) Zoloft Pfizer Inc. 2,561,069 -2.4%
7 (1) Plavix Bristol-Myers Squibb Company 2,480,042 14.3%
8 (1) Effexor XR Pfizer Inc. 2,219,469 -2.7%
9 (5) Singulair Merck 2,089,348 13.0%
10 (2) Norvasc Pfizer Inc. 2,060,364 9.4%
11 Protonix Pfizer Inc. 1,957,950 2.5%
12 (3) Ambien Pfizer Inc. 1,932,940 12.4%
13 (4) Lexapro Actavis Pharma, Inc. 1,849,528 19.2%
14 (8) Seroquel AstraZeneca 1,718,988 24.7%
15 (6) Actos Takeda Pharmaceuticals U.S.A., Inc. 1,605,016 15.6%
16 (3) Zyprexa Eli Lilly and Company 1,577,159 -16.2%
17 (2) Fosamax Merck 1,484,088 1.4%
18 (2) Risperdal Janssen Pharmaceuticals, Inc. 1,472,597 2.5%
19 (11) Avandia GlaxoSmithKline 1,381,777 31.0%
20 (6) Levaquin Janssen Pharmaceuticals, Inc. 1,348,110 19.4%
21 (15) Wellbutrin XL Bausch Health Companies Inc. 1,326,323 39.8%
22 (4) Pravachol Bristol-Myers Squibb Company 1,315,013 -13.7%
23 (5) Toprol XL AstraZeneca 1,294,098 20.3%
24 (8) OxyContin Purdue Pharma LP 1,285,922 -24.4%
25 (7) Topamax Janssen Pharmaceuticals, Inc. 1,267,766 20.5%
26 (17) Celebrex Pfizer Inc. 1,241,574 -41.3%
27 (8) Enbrel Amgen Inc. 1,130,642 18.4%
28 (6) Lotrel Novartis Pharmaceuticals Corporation 1,109,867 14.3%
29 (18) Abilify Bristol-Myers Squibb Company 1,098,379 47.0%
30 (1) Zithromax Z-Pak Pfizer Inc. 1,096,414 2.4%
31 (2) Zyrtec Johnson & Johnson Consumer Inc. 1,057,152 4.1%
32 (7) Aciphex Eisai Inc. 1,048,377 -8.0%
33 (4) Flonase GlaxoSmithKline 1,044,160 12.2%
34 (9) Lamictal GlaxoSmithKline 1,031,307 32.1%
35 (10) Adderall XR Takeda Pharmaceuticals U.S.A., Inc. 1,007,855 29.6%
36 (6) Valtrex GlaxoSmithKline 978,443 22.0%
37 (14) Allegra Sanofi 957,152 -24.1%
38 (39) Mobic Abbott Laboratories 916,397 117.6%
39 (11) Zetia Merck 904,129 31.5%
40 (6) Concerta Janssen Pharmaceuticals, Inc. 865,873 13.3%
41 (15) Coreg GlaxoSmithKline 846,802 35.2%
42 (2) Imitrex Oral GlaxoSmithKline 820,211 5.1%
43 (5) Diovan Novartis Pharmaceuticals Corporation 810,581 12.0%
44 (8) Actonel Actavis Pharma, Inc. 792,582 16.1%
45 (6) Tricor Abbott Laboratories 788,761 15.2%
46 (17) Lantus Sanofi 774,711 44.2%
47 (9) Viagra Pfizer Inc. 772,235 -14.8%
48 (7) Diovan HCT Novartis Pharmaceuticals Corporation 723,998 15.3%
49 () Vytorin Merck 715,174 >999
50 (3) Altace King Pharmaceuticals, Inc. 700,630 6.2%
51 (15) Crestor AstraZeneca 676,848 34.6%
52 (7) Aricept Eisai Inc. 651,887 11.6%
53 (1) Strattera Eli Lilly and Company 642,113 -0.6%
54 (15) Synthroid Abbott Laboratories 640,179 -26.7%
55 (12) Nasonex Merck 621,728 24.7%
56 (7) Premarin Tabs Pfizer Inc. 616,478 -12.3%
57 Lamisil Oral Novartis Pharmaceuticals Corporation 608,718 0.9%
58 (27) Omnicef Abbott Laboratories 607,482 59.4%
59 (3) Flomax Boehringer Ingelheim Pharmaceuticals, Inc. 583,267 7.7%
60 Cozaar Merck 580,627 4.0%
61 () Cymbalta Eli Lilly and Company 570,421 926.7%
62 (38) Duragesic Janssen Pharmaceuticals, Inc. 569,671 -52.9%
63 (5) Depakote Abbott Laboratories 563,228 -4.4%
64 (5) Zofran GlaxoSmithKline 554,898 12.0%
65 Detrol LA Pfizer Inc. 534,795 5.4%
66 (5) Evista Eli Lilly and Company 505,134 -7.3%
67 (5) Combivent Boehringer Ingelheim Pharmaceuticals, Inc. 501,603 10.5%
68 (20) Provigil Cephalon, Inc. 496,944 42.5%
69 (6) Pulmicort Respules AstraZeneca 486,297 12.9%
70 (3) Humalog Eli Lilly and Company 484,931 11.2%
71 (29) Lidoderm Endo Pharmaceuticals Inc. 470,692 50.0%
72 (9) Cellcept Genentech, Inc. 461,825 15.6%
73 (10) Trileptal Novartis Pharmaceuticals Corporation 458,425 14.9%
74 (2) Hyzaar Merck 448,157 4.9%
75 (7) Skelaxin Elan Corporation plc 445,377 11.5%
76 (19) Yasmin 28 Bayer HealthCare Pharmaceuticals Inc. 441,299 34.7%
77 (15) Lovenox Sanofi 438,815 32.7%
78 (8) Prograf Astellas Pharma US, Inc. 431,631 19.2%
79 (17) Depakote ER Abbott Laboratories 428,334 17.9%
80 (2) Ortho Evra Janssen Pharmaceuticals, Inc. 424,662 3.3%
81 (9) Geodon Oral Pfizer Inc. 424,003 25.5%
82 (2) Xalatan Pfizer Inc. 409,031 4.8%
83 () Allegra-D 12 Hour Sanofi 398,013 -1.4%
84 (26) Humira Abbott Laboratories 394,981 38.0%
85 (6) Procrit Janssen Biotech, Inc. 393,527 -3.1%
86 (12) Combivir GlaxoSmithKline 392,859 -9.4%
87 (24) Niaspan Abbott Laboratories 380,690 33.2%
88 (21) Keppra UCB, Inc. 379,564 31.4%
89 (29) Actiq Abbott Laboratories 370,704 41.3%
90 (3) Zithromax Pfizer Inc. 358,460 8.6%
91 (23) Clarinex Merck 353,325 -27.8%
92 (5) Avapro Bristol-Myers Squibb Company 350,899 8.5%
93 (32) Arimidex AstraZeneca 347,891 44.5%
94 (13) Zithromax Susp 342,532 18.3%
95 (27) Ortho Tri-Cyclen Lo Janssen Pharmaceuticals, Inc. 339,177 37.2%
96 (2) Asacol Actavis Pharma, Inc. 339,046 5.2%
97 () Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. 337,827 231.9%
98 (57) Paxil CR Apotex Corp. 332,100 -59.7%
99 () Truvada Gilead Sciences, Inc. 326,641 >999
100 (21) Zelnorm Novartis Pharmaceuticals Corporation 318,220 26.4%
101 (32) Reyataz Bristol-Myers Squibb Company 313,778 37.6%
102 Nasacort AQ Sanofi 311,467 0.6%
103 (1) Sustiva Bristol-Myers Squibb Company 309,140 4.2%
104 (1) Rhinocort Aqua AstraZeneca 296,463 -3.6%
105 (14) Ditropan XL Janssen Pharmaceuticals, Inc. 296,169 -11.6%
106 (57) Cialis Eli Lilly and Company 295,191 68.8%
107 (21) Xopenex Akorn, Inc. 293,131 21.9%
108 (5) Avonex Biogen 292,545 4.2%
109 () Flovent HFA GlaxoSmithKline 289,630 NA
110 (5) Copaxone Accredo Health Group, Inc. 285,940 3.7%
111 (3) Kaletra Abbott Laboratories 284,892 -1.6%
112 (58) Namenda Actavis Pharma, Inc. 283,270 74.9%
113 (6) Patanol Alcon 277,489 7.8%
114 (27) Viread Gilead Sciences, Inc. 271,732 -22.4%
115 (23) Gleevec Novartis Pharmaceuticals Corporation 270,904 29.8%
116 (18) Avalide Bristol-Myers Squibb Company 268,019 19.1%
117 () Lunesta Sepracor Inc. 264,331 >999
118 (51) Forteo Eli Lilly and Company 263,801 61.7%
119 (5) Amaryl Sanofi 262,732 -5.5%
120 (26) Avandamet GlaxoSmithKline 261,746 -20.7%
121 (3) AndroGel Abbott Laboratories 260,799 7.4%
122 (7) Avelox Bayer HealthCare Pharmaceuticals Inc. 259,386 10.2%
123 (113) Neurontin Pfizer Inc. 255,121 -87.2%
124 (1) Biaxin XL Abbott Laboratories 255,017 4.1%
125 (20) Trizivir GlaxoSmithKline 253,825 -13.0%
126 (32) Benicar Daiichi Sankyo 251,486 41.4%
127 (38) Elidel Novartis Pharmaceuticals Corporation 250,284 -28.0%
128 (3) Proscar Merck 238,949 2.5%
129 (11) Budeprion SR Teva Pharmaceuticals USA, Inc. 234,441 14.9%
130 (6) Norvir Abbott Laboratories 231,111 9.0%
131 () Benicar HCT Daiichi Sankyo 227,455 110.5%
132 (5) Aldara Medicis Pharmaceutical Corporation 226,878 8.0%
133 (61) Fuzeon Genentech, Inc. 221,322 71.1%
134 (32) Thalomid Bristol-Myers Squibb Company 217,960 28.5%
135 (8) Cefzil Bristol-Myers Squibb Company 216,930 -9.8%
136 (32) Zofran ODT GlaxoSmithKline 214,014 29.8%
137 (17) Coumadin Tabs Bristol-Myers Squibb Company 209,652 -17.2%
138 (3) Lescol XL Novartis Pharmaceuticals Corporation 208,515 -4.5%
139 (9) Augmentin XR Dr. Reddy's Laboratories, Inc. 206,072 -11.9%
140 (10) BenzaClin Sanofi 198,676 5.1%
141 (10) Humalog Mix 75/25 Pn 192,707 1.9%
142 (36) Levoxyl King Pharmaceuticals, Inc. 191,394 -34.3%
143 (16) Cosopt Akorn, Inc. 190,408 7.7%
144 (1) Trinessa Actavis Pharma, Inc. 186,951 -4.1%
145 (6) Zyrtec Syrup 186,643 -10.6%
146 (15) RenaGel Genzyme Corporation 185,001 5.3%
147 (31) Prilosec AstraZeneca 183,953 -31.1%
148 Alphagan P Actavis Pharma, Inc. 183,302 -3.4%
149 (34) Tussionex Sanofi 181,586 29.6%
150 (18) Endocet Endo Pharmaceuticals Inc. 181,043 -21.7%
151 (9) Miacalcin Nasal Mylan Pharmaceuticals Inc. 178,198 -11.7%
152 (3) Inderal LA Wyeth 177,720 -3.7%
153 (4) Klor-Con Sandoz Inc. 175,720 -7.2%
154 () Femara Novartis Pharmaceuticals Corporation 173,406 40.5%
155 (27) Mirapex Boehringer Ingelheim Pharmaceuticals, Inc. 171,769 19.9%
156 (16) Differin Galderma Laboratories, L.P. 168,877 4.5%
157 (86) Flovent GlaxoSmithKline 168,481 -63.1%
158 (5) Humulin N Eli Lilly and Company 168,427 -9.1%
159 (17) Temodar Merck 168,278 7.9%
160 (48) Ortho Tri-Cyclen Janssen Pharmaceuticals, Inc. 168,080 -40.7%
161 (20) Lumigan Actavis Pharma, Inc. 167,889 13.4%
162 (3) Casodex AstraZeneca 167,447 -2.3%
163 () Arthrotec Pfizer Inc. 164,596 39.2%
164 (18) Pegasys Genentech, Inc. 164,472 -14.2%
165 (6) Zyrtec-D Johnson & Johnson Consumer Inc. 163,573 1.1%
166 (6) Famvir GlaxoSmithKline 163,368 -7.2%
167 (10) Catapres-TTS Boehringer Ingelheim Pharmaceuticals, Inc. 163,076 5.8%
168 () Zyvox Pfizer Inc. 162,318 28.8%
169 () Relpax Pfizer Inc. 162,058 52.9%
170 (14) Xeloda Genentech, Inc. 162,024 16.0%
171 (17) DuoNeb Dey Pharma 161,270 19.6%
172 (16) Prozac Eli Lilly and Company 158,240 -12.9%
173 () Tamiflu Genentech, Inc. 157,488 389.2%
174 (4) Tobradex Alcon 155,102 0.9%
175 () NovoLog Mix 70/30 Novo Nordisk 155,049 84.6%
176 (22) Amnesteem Mylan Pharmaceuticals Inc. 153,534 -16.9%
177 (78) Ultracet Janssen Pharmaceuticals, Inc. 152,802 -52.5%
178 (5) Betaseron Bayer HealthCare Pharmaceuticals Inc. 152,108 -4.6%
179 (12) Arava Sanofi 151,574 -10.2%
180 (11) Imitrex Inj 149,914 12.1%
181 () Tarceva Astellas Pharma US, Inc. 149,525 >999
182 (8) Neupogen Amgen Inc. 148,760 -5.5%
183 (4) Atacand AstraZeneca 148,636 -3.0%
184 (153) Bextra Pfizer Inc. 148,370 -85.9%
185 () Ketek Pack 148,321 256.5%
186 () Vigamox Alcon 147,501 36.6%
187 () Aranesp Amgen Inc. 147,016 53.9%
188 () Restasis Actavis Pharma, Inc. 146,559 67.9%
189 (14) Zomig AstraZeneca 146,078 -7.1%
190 () Pulmozyme Genentech, Inc. 146,004 23.9%
191 (47) Serevent Diskus GlaxoSmithKline 144,773 -27.8%
192 () Astelin Meda U.S. 144,217 19.1%
193 (13) Humulin 70/30 Eli Lilly and Company 142,436 -6.5%
194 () Levitra Bayer HealthCare Pharmaceuticals Inc. 141,573 12.5%
195 (3) Zonegran Eisai Inc. 140,681 5.3%
196 (34) DDAVP Sanofi 140,623 -19.9%
197 () Caduet Pfizer Inc. 139,305 480.3%
198 (11) Prempro Pfizer Inc. 136,658 -0.9%
199 (58) Epivir GlaxoSmithKline 135,595 -33.1%
200 () Avinza King Pharmaceuticals, Inc. 135,037 42.3%
All Others 23,609,356 -15.8%

Source: Verispan, VONA

(By Units)

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012